3.75 WATSON 363 Pill - blue round
Pill with imprint 3.75 WATSON 363 is Blue, Round and has been identified as Clorazepate Dipotassium 3.75 mg. It is supplied by Watson Pharmaceuticals.
Clorazepate is used in the treatment of Anxiety; Alcohol Withdrawal; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for 3.75 WATSON 363
Clorazepate Dipotassium
- Imprint
- 3.75 WATSON 363
- Strength
- 3.75 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00591-0363 (Discontinued)
More about clorazepate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (54)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: benzodiazepines
- Breastfeeding
- En español
Patient resources
Other brands
Tranxene, Tranxene T-Tab, Tranxene SD
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
